Skip NavigationSkip to Content

Novel secondary Ig V-H gene rearrangement and in-frame Ig heavy chain complementarity-determining region III insertion/deletion variants in de novo follicular lymphoma

  1. Author:
    Kobrin, C. B.
    Bendandi, M.
    Kwak, L. W.
  2. Author Address

    NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Intramural Res Support Program, Bldg 567, Room 221, Frederick, MD 21702 USA. NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Intramural Res Support Program, Frederick, MD 21702 USA. NCI, Div Clin Sci, Med Branch, Dept Expt Transplantat & Immunol, Bethesda, MD 20892 USA. Kobrin CB NCI, Frederick Canc Res & Dev Ctr, Sci Applicat Int Corp, Intramural Res Support Program, Bldg 567, Room 221, Frederick, MD 21702 USA.
    1. Year: 2001
  1. Journal: Journal of Immunology
    1. 166
    2. 4
    3. Pages: 2235-2243
  2. Type of Article: Article
  1. Abstract:

    Human germinal center B cell tumors retain the ability of their nontransformed counterparts to somatically hypermutate Ig V genes by nucleotide substitution, Among a survey of 60 primary previously untreated, clonal, follicular lymphomas we have identified a rare V-H rearrangement variant and two other in- frame nucleotide insertion/deletion variants within complementarity-determining region III of the Ig heavy chain, The neoplastic origin of the V-H rearrangement variant was directly demonstrated in cells isolated by microdissection from malignant follicles. In all three cases a common clonal origin for the variants was demonstrated by complementarity- determining region III nucleotide sequence homology and shared somatic mutations in germline encoded positions in framework region IV. The monoclonal nature of the tumors was independently confirmed by demonstrating a single t(14;18) translocation breakpoint in the two cases with a detectable translocation. All the variants occurred in functional V-H rearrangements, which in two cases were directly shown to encode functional Ab molecules, Both recombination-activating genes 1 and 2 were expressed in lymph node tumor cells containing the V-H rearrangement variant, although recombination-activating gene expression among a panel of lymphomas was not limited to this variant.

    See More

External Sources

  1. No sources found.

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel